January 1, 2022· SSRN Electronic Journal
preprint
Open access
Rethinking Business Model for Drug Discovery, Post-COVID
Abstract
No abstract metadata is available for this record.
Community
0 commentsUse Connect Wallet in the navigation
No discussion yet
Be the first to share a question or observation.